Related Experiment Video

Updated: Jul 12, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

[Pulmonary complications in children with human immunodeficiency virus infection]

Pablo Brockmann V1, Támara Viviani S, Anamaría Peña D

  • 1Departamento de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile. pbrockmann@gmail.com

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|August 31, 2007
PubMed

Insights

Pediatric pulmonary complications, including pneumonia and chronic lung disease, are frequent in children with human immunodeficiency virus (HIV) infection. Early detection of atypical microorganisms is crucial for timely treatment and preventing long-term lung damage.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Pediatric HIV/AIDS

Context:

  • Pulmonary complications are a significant concern in pediatric patients with human immunodeficiency virus (HIV) infection.
  • These respiratory issues can be the initial clinical presentation of acquired immunodeficiency syndrome (AIDS).
  • Tertiary hospitals manage a substantial number of pediatric cases requiring specialized care.

Purpose:

  • To review the spectrum of pulmonary diseases and complications in children with HIV infection.
  • To analyze the types of respiratory infections and chronic lung conditions observed.
  • To identify microorganisms associated with these pulmonary issues in a specific cohort.

Summary:

  • A retrospective analysis of 17 pediatric HIV patients was conducted at a tertiary hospital in Santiago, Chile.
  • Common respiratory complications included overall pneumonia (14/17), recurrent pneumonia (10/17), and chronic pulmonary disease (7/17).
  • Specific conditions identified were cytomegalovirus pneumonia (4/17), Pneumocystis jiroveci pneumonia (1/17), pulmonary tuberculosis (1/17), and lymphoid interstitial pneumonia (3/17).
  • Atypical microorganisms were frequently isolated and linked to severe, chronic lung damage.

Impact:

  • Highlights the high burden of pulmonary disease in pediatric HIV patients.
  • Emphasizes the need for high clinical suspicion to diagnose atypical pathogens.
  • Underscores the importance of prompt, targeted therapy to mitigate long-term pulmonary sequelae in children with HIV.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...